Trial Profile

Expanded Access trial of RT001 in patients with Progressive SupraNuclear Palsy

Status: Completed

Phase of Trial: Clinical Phase Unknown

Latest Information Update: 17 May 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs RT 001 (Primary)
Indications Progressive supranuclear palsy
Focus Adverse reactions; Expanded access; Therapeutic Use
Sponsors Retrotope

Most Recent Events

17 May 2025 as full patients results are present in the result incoming, I have assumed the status as completed previously it was assumed planning from MR. Also, location has been assumed from the details given in incoming results. Pls update further.
01 May 2020 Results presented at the 72nd Annual Meeting of the American Academy of Neurology
24 Feb 2020 New trial record

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com